암 통증 치료제 시장 규모, 점유율, 성장 분석 : 약제 클래스별, 적응증별, 유통경로별, 투여 경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Cancer Pain Market size was valued at USD 7.92 Billion in 2024 and is poised to grow from USD 8.36 Billion in 2025 to USD 12.93 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global cancer pain market is experiencing significant growth driven by several key factors, including the rising incidence of cancer, an aging demographic, increased healthcare investments, and intensified research and development initiatives by healthcare organizations. As the prevalence of different cancer types escalates, particularly among older adults who are more vulnerable to age-related changes and genetic predispositions, the demand for effective pain management solutions continues to rise. Notably, various cancers, including colorectal, breast, lung, and prostate, showcase a trend where early diagnosis often occurs at advanced ages. This highlights the urgent need for comprehensive pain relief strategies in cancer care, supporting the market's expansion while also reflecting the growing focus on patient quality of life in oncology.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cancer Pain market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cancer Pain Market Segments Analysis

Global Cancer Pain Market is segmented by Drug Class, Indication, Distribution Channel, Route of Administration, End User and region. Based on Drug Class, the market is segmented into Opioids, Oxycodone, Hydrocodone, NSAIDs, Ibuprofen, Naproxen and Others. Based on Indication, the market is segmented into Lung cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy and Retail Pharmacy. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cancer Pain Market

Advancements in technology significantly improve pain management for cancer patients through the development of innovative techniques, enhanced drug delivery systems, and tailored treatment options. These breakthroughs contribute to more effective pain relief solutions, ultimately increasing accessibility for patients seeking appropriate care. As new methods emerge, they address the complexities of cancer-related pain, allowing healthcare professionals to offer more targeted and effective strategies. This ongoing evolution in the field not only elevates the standard of care but also empowers patients by providing them with personalized approaches to managing their pain, thereby improving their overall quality of life.

Restraints in the Global Cancer Pain Market

The Global Cancer Pain market faces challenges that may inhibit its expansion, particularly concerning the potential for drug tolerance, dependence, and a range of side effects related to pain medications. These concerns can create hesitancy among healthcare providers and patients when it comes to prescribing or using these treatments. Consequently, the perception of risks associated with long-term medication use may lead to increased scrutiny and caution. Additionally, the need for ongoing monitoring and adjustment of treatment plans can complicate management strategies, thereby influencing the overall growth trajectory of the market and impacting patient access to effective pain relief solutions.

Market Trends of the Global Cancer Pain Market

The Global Cancer Pain market is increasingly trending towards personalized pain management strategies, emphasizing individualized treatment approaches tailored to patients' unique genetic and molecular profiles. This shift reflects a broader movement within the healthcare sector to enhance therapeutic efficacy and minimize side effects, ultimately improving patient outcomes. As advancements in genomics and molecular biology continue to emerge, healthcare providers are adopting more precise methodologies to assess and address cancer-related pain, fostering a more patient-centric model of care. This focus on personalized treatment not only enhances the quality of life for patients but also drives innovation within the pharmaceutical and medical device industries.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Analysis
• Technology Analysis

Global Cancer Pain Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Opioids
• Oxycodone
• Hydrocodone
• NSAIDs
• Ibuprofen
• Naproxen
• Others

Global Cancer Pain Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Lung cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Blood Cancer
• Others

Global Cancer Pain Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Cancer Pain Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Parenteral
• Others

Global Cancer Pain Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Cancer Pain Market Size & CAGR (2026-2033)

• North America (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • US
  • Canada
• Europe (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Purdue Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heron Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations